This observational study identified that patients with renal failure undergoing PCI (percutaneous coronary intervention) frequently receive contraindicated anticoagulants such as enoxaparin and eptifibatide. Such exposure was associated with an increased risk of in-hospital major bleeding.
- Enoxaparin Outcomes in Patients With Moderate Renal Impairment
- Acetylcysteine for Prevention of Renal Outcomes in Patients Undergoing Coronary and Peripheral Vascular Angiography: Main Results From the Randomized Acetylcysteine for Contrast-Induced Nephropathy Trial (ACT)
- Perioperative Aspirin and Clonidine and Risk of Acute Kidney Injury